Cargando…

Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II

OBJECTIVES: We aimed to explore the association between metformin treatment and epithelial-mesenchymal transition (EMT) phenotype and further appraise the prognostic values of metformin and EMT markers E-cadherin and vimentin for colorectal cancer (CRC) in clinical practice. METHODS: We collected sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yaodu, Wu, Zhiyang, Hu, Likuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506476/ https://www.ncbi.nlm.nih.gov/pubmed/28744307 http://dx.doi.org/10.1155/2017/2520581

Ejemplares similares

RBP2 Induces Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer
por: Wang, Shikun, et al.
Publicado: (2013)

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer
por: Al Omari, Amal, et al.
Publicado: (2018)

Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
por: Powell, Marta K., et al.
Publicado: (2019)

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus
por: Tarhini, Zeinab, et al.
Publicado: (2022)

Metformin Ameliorates Epithelial–Mesenchymal Transition of Renal Tubular Epithelial Cells in Diabetes by Increasing Vitamin D Receptor Expression
por: Wen, Wenjie, et al.
Publicado: (2022)

Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer
por: Wu, Fengjie, et al.
Publicado: (2017)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
por: Lu, Jian, et al.
Publicado: (2023)

Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
por: Chengye, Wang, et al.
Publicado: (2017)

Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
por: Park, Ji‐Hye, et al.
Publicado: (2019)

TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer
por: Hu, Cheng-En, et al.
Publicado: (2017)

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition
por: Ayinde, Oluseyi, et al.
Publicado: (2019)

Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer
por: Qu, Qingxi, et al.
Publicado: (2022)

Metformin down-regulates epithelial-mesenchymal transition (EMT) in fibroblasts from burned patients
por: Wetzel, Michael, et al.
Publicado: (2014)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells
por: Zhi, Yidan, et al.
Publicado: (2015)

Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition
por: Liu, Qiqi, et al.
Publicado: (2021)

The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)

Metformin attenuates cells stemness and epithelial-mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β-catenin pathway
por: Zhang, Chu, et al.
Publicado: (2019)

Phenotypic Characterization of Colorectal Liver Metastases: Capsule versus No Capsule and the Potential Role of Epithelial Mesenchymal Transition
por: Fleig, Claudia, et al.
Publicado: (2023)

Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus
por: Sun, Lin, et al.
Publicado: (2011)

Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
por: Zhao, Zhongquan, et al.
Publicado: (2014)

Epithelial–mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model
por: Veloso, Emerson Soares, et al.
Publicado: (2022)

Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT)
por: Chang, Yu-Jia, et al.
Publicado: (2016)

Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability
por: García de Herreros, Antonio
Publicado: (2014)

Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)

Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer
por: Cai, Du, et al.
Publicado: (2023)

Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition
por: Hong, Deli, et al.
Publicado: (2017)

The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition
por: Subbalakshmi, Ayalur Raghu, et al.
Publicado: (2023)

Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework
por: Bozzi, Fabio, et al.
Publicado: (2016)

The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
por: Gulla, Aiste, et al.
Publicado: (2022)

SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
por: Zhang, Xiaotian, et al.
Publicado: (2022)

PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition
por: Weng, Xingyue, et al.
Publicado: (2019)

Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer
por: Wu, Yuhui, et al.
Publicado: (2021)

Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
por: Koch, Katharina, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
por: Loeffler, Ivonne, et al.
Publicado: (2015)

Epithelial to mesenchymal transition and the cancer stem cell phenotype: Insights from cancer biology with therapeutic implications for colorectal cancer
por: Findlay, Victoria J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c1fpedoej2m6himu62urmsj1b2